Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 milligrams daily in patients with pulmonary tuberculosis

R. E. Aarnoutse, G. S. Kibiki, K. Reither, H. H. Semvua, F. Haraka, C. M. Mtabho, S. G. Mpagama, J. van den Boogaard, I. M. Sumari-de Boer, C. Magis-Escurra, M. Wattenberg, J. G.M. Logger, L. H.M. te Brake, M. Hoelscher, S. H. Gillespie, A. Colbers, P. P. J. Phillips, G. Plemper van Balen, M. J. Boeree, PanACEA Consortium

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 milligrams daily in patients with pulmonary tuberculosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science